PMID: 25731353Mar 4, 2015Paper

Three cases of anal squamous cell carcinoma treated with chemoradiotherapy

Gan to kagaku ryoho. Cancer & chemotherapy
Yasunori SomenoKenichi Sugihara

Abstract

We reviewed the clinical records of 3 patients with anal squamous cell carcinoma treated with chemoradiotherapy (CRT). Case 1: The patient was diagnosed with StageI (T1N0M0) and treated with cisplatin (CDDP)+5-FU+radiation. Chemotherapy was discontinued after the second course because of adverse effects. She achieved partial response(PR), and underwent a salvage surgery. Seven months after the surgery, she died from other comorbidities. Case 2: The patient was diagnosed with Stage I (T1N0M0) and treated with CDDP+5-FU+radiation. Chemotherapy was discontinued after the second course because of adverse effects. He achieved PR, and underwent a salvage surgery. Three years and 7 months after the surgery, he died from other comorbidities. Case 3: The patient was diagnosed with Stage IIIB (T4N1M0) and treated with MMC+S-1+radiation. Chemotherapy was discontinued after the first course because of adverse effects. She achieved complete response (CR) and is still surviving without cancer recurrence. We conclude that CRT is an effective treatment for anal squamous cell carcinoma.

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

Gan to kagaku ryoho. Cancer & chemotherapy
Shinnosuke YonaiyamaHideo Kawaguchi
Gan to kagaku ryoho. Cancer & chemotherapy
Harunobu SatoKoutarou Maeda
Gan to kagaku ryoho. Cancer & chemotherapy
Harunobu SatoMasayoshi Fukuda
Gan to kagaku ryoho. Cancer & chemotherapy
Harunobu SatoKoutarou Maeda
© 2022 Meta ULC. All rights reserved